Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Breast-Cancer-2022-1000x250

The abstract submission system is now closed

Outcome notifications

Outcome notifications are expected to be made available to first authors by mid-March 2022.

Abstract submission deadlines

Abstracts

Deadlines

  • Abstracts
  • Trial in Progress (TiP)
  • Intent to submit LBA

15 February 2022, 21:00 CET (Central European Time) 

Late-breaking abstracts (LBA)

5 April 2022*, 21:00 CEST (Central European Summer Time)

*A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline 15 February 2022.

Abstract Submission Categories

  • Biomarkers and translational research and precision medicine
  • Early breast cancer: Adjuvant therapy
  • Early breast cancer: Neoadjuvant therapy
  • Early breast cancer: Surgery and radiotherapy
  • Early detection, hereditary breast cancer and prevention
  • Immunotherapy
  • Metastatic breast cancer
  • Supportive care and survivorship
  • Miscellaneous

Publication schedule of accepted abstracts

  • Abstracts accepted for presentation during ESMO Breast Cancer 2022 (Proffered Paper, Mini Oral and Poster) and for publication in the ESMO Breast Cancer 2022 Abstract Book, will be published online on the ESMO Breast Cancer 2022 website on Monday, 2 May 2022.
  • Late-breaking abstracts (LBA) accepted for presentation during ESMO Breast Cancer 2022 will be made public on the day of presentation during the official ESMO Breast Cancer 2022 Programme.

Abstracts

Deadlines

Abstracts accepted as:

  • Proffered Paper (suffix ‘O’)
  • Mini Oral (suffix ‘MO’)
  • Poster (suffix ‘P’, ‘TiP’)

2 May 2022, 12:00 Central European Summer Time (CEST).

Late-breaking abstracts (prefix ‘LBA’)

At the start of the official Congress session during which they are presented

Presentation of accepted abstracts

The Breast Cancer 2022 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

  • Proffered Paper (oral presentation) – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Mini oral – Short presentation by the authors with comment and interactive audience discussion led by an invited expert.
  • Poster – An important method for communicating details of scientific research, posters will be on display for the duration of the Congress.

Publications

All accepted abstracts will be published as a supplement to the official ESMO journal Annals of Oncology. 

Travel Grants

A restricted number of travel grants to the ESMO Breast Cancer 2022 are available, upon application, to first author (= presenter) of candidates under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by the ESMO Breast Cancer 2022 Scientific Committee on a competitive basis from among the accepted abstracts.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.